Daniel T Meier1,2, Leon Entrup1,2, Andrew T Templin1,2, Meghan F Hogan1,2, Mahnaz Mellati1,2, Sakeneh Zraika1,2, Rebecca L Hull1,2, Steven E Kahn3,4. 1. VA Puget Sound Health Care System, 1660 S. Columbian Way, Seattle, WA, 98108, USA. 2. University of Washington, Seattle, WA, USA. 3. VA Puget Sound Health Care System, 1660 S. Columbian Way, Seattle, WA, 98108, USA. skahn@uw.edu. 4. University of Washington, Seattle, WA, USA. skahn@uw.edu.
Abstract
AIMS/HYPOTHESIS: The S20G human islet amyloid polypeptide (hIAPP) substitution is associated with an earlier onset of type 2 diabetes in humans. Studies of synthetic S20G hIAPP in cell-free systems and immortalised beta cells have suggested that this may be due to increased hIAPP amyloidogenicity and cytotoxicity. Thus, using primary islets from mice with endogenous S20G hIAPP expression, we sought to determine whether the S20G gene mutation leads to increased amyloid-induced toxicity, beta cell loss and reduced beta cell function. METHODS: Islets from mice in which mouse Iapp was replaced with human wild-type or S20G hIAPP were isolated and cultured in vitro under amyloid-forming conditions. Levels of insulin and hIAPP mRNA and protein, amyloid deposition and beta cell apoptosis and area, as well as glucose-stimulated insulin and hIAPP secretion, were quantified. RESULTS: Islets expressing S20G hIAPP cultured in 16.7 mmol/l glucose demonstrated increased amyloid deposition and beta cell apoptosis, reduced beta cell area, decreased insulin content and diminished glucose-stimulated insulin secretion, compared with islets expressing wild-type hIAPP. Amyloid deposition and beta cell apoptosis were also increased when S20G islets were cultured in 11.1 mmol/l glucose (the concentration that is thought to be physiological for mouse islets). CONCLUSIONS/ INTERPRETATION: S20G hIAPP reduces beta cell number and function, thereby possibly explaining the earlier onset of type 2 diabetes in individuals carrying this gene mutation.
AIMS/HYPOTHESIS: The S20Ghuman islet amyloid polypeptide (hIAPP) substitution is associated with an earlier onset of type 2 diabetes in humans. Studies of synthetic S20GhIAPP in cell-free systems and immortalised beta cells have suggested that this may be due to increased hIAPP amyloidogenicity and cytotoxicity. Thus, using primary islets from mice with endogenous S20GhIAPP expression, we sought to determine whether the S20G gene mutation leads to increased amyloid-induced toxicity, beta cell loss and reduced beta cell function. METHODS: Islets from mice in which mouseIapp was replaced with human wild-type or S20GhIAPP were isolated and cultured in vitro under amyloid-forming conditions. Levels of insulin and hIAPP mRNA and protein, amyloid deposition and beta cell apoptosis and area, as well as glucose-stimulated insulin and hIAPP secretion, were quantified. RESULTS: Islets expressing S20GhIAPP cultured in 16.7 mmol/l glucose demonstrated increased amyloid deposition and beta cell apoptosis, reduced beta cell area, decreased insulin content and diminished glucose-stimulated insulin secretion, compared with islets expressing wild-type hIAPP. Amyloid deposition and beta cell apoptosis were also increased when S20G islets were cultured in 11.1 mmol/l glucose (the concentration that is thought to be physiological for mouse islets). CONCLUSIONS/ INTERPRETATION:S20GhIAPP reduces beta cell number and function, thereby possibly explaining the earlier onset of type 2 diabetes in individuals carrying this gene mutation.
Authors: Daniel T Meier; Leon Entrup; Andrew T Templin; Meghan F Hogan; Thanya Samarasekera; Sakeneh Zraika; Edward J Boyko; Steven E Kahn Journal: J Histochem Cytochem Date: 2015-08 Impact factor: 2.479
Authors: S Sakagashira; T Sanke; T Hanabusa; H Shimomura; S Ohagi; K Y Kumagaye; K Nakajima; K Nanjo Journal: Diabetes Date: 1996-09 Impact factor: 9.461
Authors: Catherine A Jurgens; Mirna N Toukatly; Corinne L Fligner; Jayalakshmi Udayasankar; Shoba L Subramanian; Sakeneh Zraika; Kathryn Aston-Mourney; Darcy B Carr; Per Westermark; Gunilla T Westermark; Steven E Kahn; Rebecca L Hull Journal: Am J Pathol Date: 2011-06 Impact factor: 4.307
Authors: Z Ma; G T Westermark; S Sakagashira; T Sanke; A Gustavsson; H Sakamoto; U Engström; K Nanjo; P Westermark Journal: Amyloid Date: 2001-12 Impact factor: 7.141
Authors: S Zraika; R L Hull; J Udayasankar; K Aston-Mourney; S L Subramanian; R Kisilevsky; W A Szarek; S E Kahn Journal: Diabetologia Date: 2009-01-16 Impact factor: 10.122
Authors: Andrew T Templin; Mahnaz Mellati; Daniel T Meier; Nathalie Esser; Meghan F Hogan; Joseph J Castillo; Rehana Akter; Daniel P Raleigh; Sakeneh Zraika; Rebecca L Hull; Steven E Kahn Journal: Diabetologia Date: 2020-07-29 Impact factor: 10.122
Authors: Aleksandr Kakinen; Yanting Xing; Nuwan Hegoda Arachchi; Ibrahim Javed; Lei Feng; Ava Faridi; Alon M Douek; Yunxiang Sun; Jan Kaslin; Thomas P Davis; Michael J Higgins; Feng Ding; Pu Chun Ke Journal: Nano Lett Date: 2019-08-29 Impact factor: 11.189
Authors: Qin Cao; David R Boyer; Michael R Sawaya; Romany Abskharon; Lorena Saelices; Binh A Nguyen; Jiahui Lu; Kevin A Murray; Fouad Kandeel; David S Eisenberg Journal: Nat Struct Mol Biol Date: 2021-09-09 Impact factor: 18.361
Authors: Yong Xu; Roberto Maya-Martinez; Nicolas Guthertz; George R Heath; Iain W Manfield; Alexander L Breeze; Frank Sobott; Richard Foster; Sheena E Radford Journal: Nat Commun Date: 2022-02-24 Impact factor: 17.694
Authors: Christine Röder; Tatsiana Kupreichyk; Lothar Gremer; Luisa U Schäfer; Karunakar R Pothula; Raimond B G Ravelli; Dieter Willbold; Wolfgang Hoyer; Gunnar F Schröder Journal: Nat Struct Mol Biol Date: 2020-06-15 Impact factor: 15.369
Authors: Rodrigo Gallardo; Matthew G Iadanza; Yong Xu; George R Heath; Richard Foster; Sheena E Radford; Neil A Ranson Journal: Nat Struct Mol Biol Date: 2020-09-14 Impact factor: 15.369
Authors: Ewa A Mirecka; Sophie Feuerstein; Lothar Gremer; Gunnar F Schröder; Matthias Stoldt; Dieter Willbold; Wolfgang Hoyer Journal: Sci Rep Date: 2016-09-19 Impact factor: 4.379